KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Co-Diagnostics (CODX) Return on Assets (2017 - 2025)

Historic Return on Assets for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to 0.71%.

  • Co-Diagnostics' Return on Assets fell 1700.0% to 0.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71%, marking a year-over-year decrease of 1700.0%. This contributed to the annual value of 0.47% for FY2024, which is 1500.0% down from last year.
  • According to the latest figures from Q3 2025, Co-Diagnostics' Return on Assets is 0.71%, which was down 1700.0% from 0.71% recorded in Q2 2025.
  • Over the past 5 years, Co-Diagnostics' Return on Assets peaked at 0.67% during Q1 2021, and registered a low of 0.71% during Q2 2025.
  • Its 5-year average for Return on Assets is 0.16%, with a median of 0.33% in 2023.
  • Its Return on Assets has fluctuated over the past 5 years, first skyrocketed by 11900bps in 2021, then plummeted by -5100bps in 2023.
  • Over the past 5 years, Co-Diagnostics' Return on Assets (Quarter) stood at 0.28% in 2021, then crashed by -138bps to 0.11% in 2022, then plummeted by -230bps to 0.35% in 2023, then plummeted by -59bps to 0.55% in 2024, then decreased by -28bps to 0.71% in 2025.
  • Its Return on Assets was 0.71% in Q3 2025, compared to 0.71% in Q2 2025 and 0.6% in Q1 2025.